Drug intelligence / Profile preview

phentermine + amphetamine

Development stage
Unknown
Lead developer
Teva Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Phentermine + amphetamine refers to the concurrent use of two central nervous system stimulants, phentermine and amphetamine. Both are sympathomimetic amines that act as stimulants, increasing the release of neurotransmitters such as dopamine and norepinephrine in the brain. Phentermine is primarily used as a short-term adjunct for weight loss in obesity management, while amphetamines (including dextroamphetamine/amphetamine combinations like Adderall) are mainly prescribed for attention deficit hyperactivity disorder (ADHD) and narcolepsy. The combination is not an approved pharmaceutical product but may be encountered when both drugs are prescribed together off-label. Both agents increase heart rate and blood pressure, so their combined use can enhance cardiovascular risks such as hypertension and tachycardia[1][4][5]. Mechanistically, both drugs stimulate the central nervous system by promoting catecholamine release.

02

Targets

TAAR1 (Trace amine-associated receptor 1)DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on phentermine + amphetamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phentermine + amphetamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call